ACI

Thursday, Oct. 23, 2025 | 1–3 p.m. ET
National Harbor, MD

Register Now

The ACI Session at APSHO’s JADPRO Live: Managing Multi-Organ Toxicities Associated With Cell Therapies and Immune Checkpoint Inhibitors will be held in person at the 2025 JADPRO Live Annual APSHO Meeting in National Harbor, MD.

New for 2025

  • Discuss immune-related adverse events and toxicities from the perspectives of advanced practice providers.
  • Address the mechanisms and management of toxicities associated with bispecific T cell engagers, differentiating between renal and hepatic toxicities in combination immunotherapies, and managing overlap syndromes like Triple M (myastehnia gravis, myositis, and myocarditis).
The 2025 Advances in Cancer Immunotherapy™ series is supported, in part, through independent medical education grants from AstraZeneca, GSK, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., and Replimune Inc. (supporters as of Apr. 1, 2025).

Program Organizers

Marianne Davies, DNP, ACNP, AOCNP, FAAN (Chair)

Marianne Davies, DNP, ACNP, AOCNP, FAAN
Smilow Cancer Hospital at Yale

Lisa A. Kottschade, APRN, MSN, CNP

Lisa A. Kottschade, APRN, MSN, CNP
Mayo Clinic

Program Snapshot

Program Date & Location

Thursday, Oct. 23, 2025 at 1–3 P.M. ET
Gaylord National Resort Hotel & Convention Center
201 Waterfront St
Oxon Hill, MD 20745

Program Date & Location

Thursday, June 5, 2025 at 8 A.M.–12 P.M. CT
Chicago, IL

Register for ACI Session at the 2025 JADPRO Live Meeting >

Program Agenda

1:05 p.m.

 

Welcome & Introduction

1:05–1:35 p.m.

 
Toxicities with BiTE Therapies: Mechanisms of Action and Managing CRS and Neurotoxicities 
Beth Sandy, MSN, CRNP, FAPO – Penn Medicine

1:35–2:05 p.m.

  
Renal and Hepatic: Differential Dx in combination therapy
Marianne Davies, DNP, ACNP, AOCNP, FAAN – Smilow Cancer Hospital at Yale

2:05–2:35 p.m.

 

Challenging Triple M: Myocarditis, myositis, MG 
Anecita Fadol PhD, APRN, FAANN, FAAN – MD Anderson Cancer Center
Lisa Kottschade, APRN, MSN, CNP, FAPO – Mayo Clinic

2:35–3:00 p.m.

 

Case Study Panel Discussion and Q&A 

3:00 p.m.

 

Closing Remarks

SITC ACI Series

This program is part of the SITC ACI series. View below to explore more programs in the 2025 ACI series.

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.